Osteoporosis Awareness Among Nursing Students

September 29, 2026 updated by: Esra Cavusoglu, Mersin University

Effect of Scenario-based Teaching on Osteoporosis Awareness in Nursing Students: A Randomized Controlled Trial

The aim of this clinical study is to determine the effect of scenario-based training of nursing students on awareness of osteoporosis.

To this end, the most important questions to be answered in the study are

  • What is the level of osteoporosis awareness among nursing students at the start of the study?
  • Does scenario-based education have an impact on osteoporosis awareness?

Participants:

All student nurses participating in the study will first receive theoretical training on osteoporosis. At the end of the training, a scenario example prepared by the researchers on the topic of osteoporosis is worked on with the students in the experimental group. No additional intervention is carried out with the control group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In this study, 124 nursing students randomly assigned to the experimental and control groups are first interviewed using the personal information questionnaire and the Osteoporosis Awareness Scale. This is followed by a four-hour theoretical lesson prepared by the researchers in accordance with current literature and textbooks on osteoporosis as part of the Joint and Connective Tissue Diseases and Nursing course. At the end of the theoretical lessons, a scenario example prepared by the researchers, again using current literature and case presentations, will be worked on with the students in the experimental group. No other application is made for the control group. The Personal Information Questionnaire and the Osteoporosis Awareness Scale will be re-administered to both groups four weeks after the end of the theoretical lesson.

Study Type

Interventional

Enrollment (Actual)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yenişehir
      • Mersin, Yenişehir, Turkey (Türkiye)
        • Mersin University Faculty of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age and above,
  • Mersin University Faculty of Nursing 2nd year students,
  • Have not received any other training on osteoporosis before,
  • Willing to participate in the research,
  • Have cognitive competence to fill out the data collection form,
  • Those who sign the Informed Voluntary Consent Form will be included.

Exclusion Criteria:

  • Those under the age of 18,
  • Not a 2nd year student at Mersin University Faculty of Nursing,
  • Have previously received different training on osteoporosis,
  • Do not want to participate in the research,
  • Do not have the cognitive ability to fill out the data collection form,
  • Those who do not sign the Informed Consent Form will not be included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group: Scenario group

Theoretical lesson on osteoporosis and a scenario example on osteoporosis will be covered with the experimental group.

The experimental group will first be given a theoretical lesson prepared in line with the current literature on osteoporosis. At the end of the lesson, a prepared scenario example on osteoporosis will be covered.

Other: Other: Control group

The control group will be given a theoretical lesson on osteoporosis. No additional intervention will be made.

The control group will only be given a theoretical lesson prepared in line with the current literature on osteoporosis. No other intervention will be made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Osteoporosis awareness level will be assessed using the Osteoporosis Awareness Scale.
Time Frame: Change from before implementation and 4th week of practice

The Osteoporosis Awareness Scale consists of 31 items and 5 subscales. Responses to scale items are rated on a 4-point Likert-type scale ranging from 1 to 4 (4 = I know very well, 3 = I know, 2 = I know a little, 1 = I don't know at all). The lowest and highest possible scores from the scale are 31 and 124, respectively. The higher the average score obtained from the overall scale, the higher the osteoporosis awareness.

Change from before implementation and 4th week of practice

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Esra Çavuşoğlu, Doctorate, Mersin University
  • Principal Investigator: Meral Gün, Doctorate, Mersin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2024

Primary Completion (Actual)

November 25, 2024

Study Completion (Actual)

February 20, 2025

Study Registration Dates

First Submitted

December 30, 2024

First Submitted That Met QC Criteria

December 30, 2024

First Posted (Actual)

January 7, 2025

Study Record Updates

Last Update Posted (Actual)

October 2, 2026

Last Update Submitted That Met QC Criteria

September 29, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MersinUni.

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.